TAG:
the clinical laboratory
Why Patient Safety Is Change Agent for Labs
By Robert Michel | From the Volume X No. 4 – March 24, 2003 Issue
CEO SUMMARY: In the 1990s, managed care was the dominant change agent to the nation’s healthcare system. During the 2000s, it will be patient safety. However, unlike the unpleasant consequences of HMOs, capitation, and utilization risk, patient safety will prove to be a benevolent trend…
“March 24, 2003 Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume X No. 4 – March 24, 2003 Issue
Wholesale prices for general acute care hospitals has climbed steadily in recent months. As tracked by the U.S. Labor Department’s Wholesale Producer Price Index, hospital prices increased 0.5%. For the 12 months ending in February, hospital prices were up 4.7%. This is almost doub…
New Trends in 2003 Affect Clinical Lab Services
By Robert Michel | From the Volume X No. 1 – January 20, 2003 Issue
CEO SUMMARY: Here’s our current list of macro trends that affect clinical laboratories, updated from the last list in January 2000. One bold prediction is that Medicare, as we know it, is on the verge of a major meltdown. Employers and consumers are also new forces to be reckoned with b…
Patient Safety is Related to “Quality Management”
By R. Lewis Dark | From the Volume IX No. 17 – December 9, 2002 Issue
REMEMBER BACK IN 1997 WHEN LABORATORY COMPLIANCE PROGRAMS were mandated by Medicare officials? That was a big thing in the laboratory industry. Every laboratory organization in the United States scrambled to assess their laboratory’s operating practices, develop policies, and create a compliance ma…
More Consolidation: Where Will It Lead?
By R. Lewis Dark | From the Volume IX No. 16 – November 18, 2002 Issue
I CERTAINLY DID NOT FORESEE ALL THE LAB ACQUISITION ACTIVITY that occurred during 2002. Compared to recent years, both Quest Diagnostics Incorporated and Laboratory Corporation of America have been on a buying spree this year. Quest Diagnostics acquired Amer…
MT/MLT Training Insights From Calif. University
By Robert Michel | From the Volume IX No. 15 – October 28, 2002 Issue
CEO SUMMARY: Laboratory administrators from 15 San Francisco Bay Area hospitals recently approached their CEOs and requested a five-year funding commitment of $1.5 million to train and expand the supply of CLSs and MTs. One key element in this effort was the enthusiastic support of those …
Major Changes at Dade Behring Soon to Be Visible In Lab Market
By Robert Michel | From the Volume IX No. 15 – October 28, 2002 Issue
Its recent financial restructuring now complete, Dade Behring prepares a “brand building” campaign CEO SUMMARY: Dade Behring is poised to become a tough and high-profile competitor in the laboratory diagnostics marketplace. Earlier this month,…
Florida Appeals Court Strikes Blow To Clinical Path Payment
By Robert Michel | From the Volume IX No. 11 – August 5, 2002 Issue
LEGAL ARGUMENTS SUPPORTING payment for clinical pathology professional services were dealt a blow when Florida’s Fifth District Court of Appeal issued an unfavorable ruling on July 12 in Daytona Beach, Florida. “The import of the court’s ruling seems to be that a pathologist in Florida cannot …
Boost for Consumer Choice in Healthcare
By R. Lewis Dark | From the Volume IX No. 10 – July 15, 2002 Issue
OVERLOOKED BY MOST LAB EXECUTIVES AND PATHOLOGISTS was a ruling made last month by the Internal Revenue Service (IRS). It was a significant ruling, but neither the media nor many people in the United States understood its significance. As a result, this ruling got little news coverage. But for the l…
Aetna, AmeriPath, DIANON, IMPATH, JCAHO
By Robert Michel | From the Volume IX No. 10 – July 15, 2002 Issue
AETNA RECOMMENDS PAYERS SUPPORT GENETIC SCREENING TESTS ALL LABORATORIANS SHOULD send a special note of thanks to Aetna Chairman and CEO John W. Rowe, M.D. for his recommendation that the health industry support the concept of genetic testing. He made these recommendations as part of speech…
CURRENT ISSUE

Volume XXXII, No. 13 – September 15, 2025
The Dark Report examines a new bill that would reform PAMA and avoid reimbursement rate cuts scheduled for January 2026. Clinical laboratory leaders are urged to make their voices heard in Congress. Also, an expert describes how labs can fix pre-analytical errors and avoid disaster.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized